Adenocarcinoma of the prostate with small cell component and low levels of prostate specific antigen

Adenocarcinoma of the prostate with small cell component and low levels of prostate specific antigen

Introduction. Prostate cancer is one of the most common malignancies in men. The most common type is acinar adenocarcinoma. Small cell prostate cancer (SCPC) usually occurs together with coexisting prostate adenocarcinoma. Case report. A 72-years-old patient with voiding simptoms is presented. Initi...

Full description

Bibliographic Details
Main Authors:	Vojinov Saša, Popov Mladen, Levakov Ivan, Levakov-Fejsa Aleksandra, Jeremić Dimitrije, Grbić Dragan
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2020-01-01
Series:	Vojnosanitetski Pregled
Subjects:	prostatic neoplasms prostate-specific antigen diagnostic techniques and procedures prostatectomy drug therapy prognosis
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501900029V.pdf

Similar Items

Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade
by: Vojinov Saša, et al.
Published: (2011-01-01)

Prostate-specific antigen 10–20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6
by: Glen Denmer R. Santok, et al.
Published: (2017-03-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
by: Marcos F. Dall'Oglio, et al.
Published: (2005-10-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
by: Dan Bee Lee, et al.
Published: (2023-01-01)

Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01)

Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer
by: Yu-Cheng Lu, et al.
Published: (2021-01-01)

CRISP3 glycoprotein: a good biomarker for prostate cancer?
by: Aparecida de Lourdes Carvalho, et al.
Published: (2021-05-01)

Incidental prostate cancer: a 23-year review of a tertiary care hospital
by: Abdul khalique, et al.
Published: (2023-07-01)

DIAGNOSIS OF PROSTATIC NEOPLASM LATER TO ANTIBIOTIC TREATMENT IN PATIENTS WITH PROSTATE-SPECIFIC ANTIGEN BETWEEN 4 AND 10 ng/ml (IN SPANISH)
by: Infantes-Burgos Ronald Javier, et al.
Published: (2014-01-01)

Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
by: Jun Seok Kim, et al.
Published: (2015-04-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Association between PSA values and surveillance quality after prostate cancer surgery
by: Christina Hunter Chapman, et al.
Published: (2019-12-01)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
by: Hee Ju Cho, et al.
Published: (2014-12-01)

Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
by: Victor Srougi, et al.
Published: (2011-08-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Biochemical recurrence after radical prostatectomy: what does it mean?
by: Rafael Tourinho-Barbosa, et al.

Does index tumor predominant location influence prognostic factors in radical prostatectomies?
by: Athanase Billis, et al.

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
by: Zujaja Hina Haroon, et al.
Published: (2022-03-01)

Correlation between prostate-specific antigen and histopathological difference of prostate carcinoma
by: Živković Slađana
Published: (2004-01-01)

Prevalence of prostate adenocarcinoma according to race in an university hospital
by: Milton S Barros, et al.
Published: (2003-08-01)

Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer
by: Marcos D. Ferreira, et al.
Published: (2005-04-01)

Bilateral Cancer in Prostate Biopsy Associates with the Presence of Extracapsular Disease and Positive Surgical Margins in Low Risk Patients: A Consideration for Bilateral Nerve Sparing Radical Prostatectomy Decision
by: Stavros Sfoungaristos, et al.
Published: (2013-09-01)

Renal dysplasia with the ipsilateral ectopic ureter mimicking abscess of the prostate
by: Grbić Dragan, et al.
Published: (2014-01-01)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
by: Philipp Mandel, et al.
Published: (2021-07-01)

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy
by: Ernani L. Rhoden, et al.
Published: (2003-04-01)

Significance of the correlation between serum-prostate specific antigen and the percentage of prostate cancer volume in postoperative biochemical progression
by: Spasić Aleksandar, et al.
Published: (2017-01-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
by: Benjamin T. Ristau, et al.

Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis
by: Yan Jin, et al.
Published: (2022-05-01)

Analysis of prostate cancer in Tamil Nadu and Pondicherry: Are we missing the boat?
by: A Mukherjee, et al.
Published: (2006-01-01)

Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy
by: Gan-Sheng Xie, et al.
Published: (2016-01-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.